TC regimen
WikiDoc Resources for TC regimen |
Articles |
---|
Most recent articles on TC regimen |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on TC regimen at Clinical Trials.gov Clinical Trials on TC regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on TC regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on TC regimen Discussion groups on TC regimen Patient Handouts on TC regimen Directions to Hospitals Treating TC regimen Risk calculators and risk factors for TC regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for TC regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: Taxotere-Cyclophosphamide regimen
Overview
TC regimen refers to a regimen consisting of docetaxel and cyclophosphamide used to treat breast cancer.[1]
Regimen
TDocetaxel (Taxotere)
CCyclophosphamide (Cytoxan)
Indications
References
- ↑ 1.0 1.1 Jones SE, Savin MA, Holmes FA, O'Shaughnessy JA, Blum JL, Vukelja S; et al. (2006). "Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer". J Clin Oncol. 24 (34): 5381–7. doi:10.1200/JCO.2006.06.5391. PMID 17135639.